Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

5,000 men with advanced prostate cancer to be tracked in new registry study

NCT ID NCT06835218

Knowledge-focused Sponsor: UroTrials Company (GmbH) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is a registry that will follow about 5,000 men with prostate cancer that has come back or spread. It aims to record which treatments doctors actually use in routine care and how the disease progresses over time. Participants are grouped by their cancer stage, from PSA recurrence to metastatic castration-resistant disease. No new treatment is given; the study simply observes and collects data to improve future care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 5,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2024

Expected to finish

Dec 2032

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult prostate cancer patients (age ≥18 years) who will receive a new line of systemic therapy at the time of study entry or up to 4 weeks thereafter.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult prostate cancer patients (age ≥18 years). * Diagnosis at time of study inclusion Cohort 1: biochemical recurrence (BCR) after local curative intended treatment (e.g. radical prostatectomy, radiotherapy of the prostate or combination thereof) Cohort 2: non-metastatic castration-resistant prostate cancer (nmCRPC) or Cohort 3: metastatic hormone sensitive prostate cancer (mHSPC) or Cohort 4: metastatic castration-resistant prostate cancer (mCRPC) (irrespective of treatment choice, treatment line) * Patients who will receive a new line of systemic therapy at the time of study entry or up to 4 weeks thereafter. Regarding Cohort 4 this includes patients with a new diagnosis of mCRPC (=first line mCRPC) after either treatment for mHSPC or non-metastatic CRPC as well as patients with prior mCRPC treatments (2nd, 3rd, … line). * For Cohorts 1, 2 and 3: Disease proven by clinical measures (i.e. standard imaging) to be either unsuitable for local salvage treatment (e.g. surgery, radiotherapy) or local treatment is declined by the patient. * Patients, who are able and willing to sign the informed consent form Exclusion Criteria: • Patients who are not eligible for observation due to severe comorbidities or unavailability according to the treating physician

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Biochemical recurrence of malignant neoplasm of prostate are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

castration-resistant prostate carcinoma metastatic prostate carcinoma neoplasm Neoplasm Metastasis prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Biochemical recurrence of malignant neoplasm of prostate Metastatic castration resistant prostate cancer Metastatic hormone-sensitive prostate cancer (MHSPC) Non-metastatic castration-resistant prostate cancer Prostate cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    53 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • "Brüder" Hospital St. Joseph Paderborn

    RECRUITING

    Paderborn, North Rhine-Westphalia, 33098, Germany

  • "Vivantes Prostatazentrum" Hospital "am Urban"

    RECRUITING

    Berlin, Brandenburg, 10967, Germany

  • Caritas-Hospital St. Josef

    RECRUITING

    Regensburg, Bavaria, 93053, Germany

  • Center for Urology Boxberg

    RECRUITING

    Neunkirchen, Saarland, 66538, Germany

  • City Hospital Dessau

    RECRUITING

    Dessau, Saxony-Anhalt, 06847, Germany

  • Hospital "Barmherzigen Brüder "Trier

    RECRUITING

    Trier, Rhineland-Palatinate, 54292, Germany

  • Hospital Bayreuth GmbH

    RECRUITING

    Bayreuth, Bavaria, 95445, Germany

  • Hospital Kempten

    RECRUITING

    Kempten (Allgäu), Bavaria, 87439, Germany

  • Hospital Nürnberg North

    RECRUITING

    Nuremberg, Bavaria, 90419, Germany

  • Hospital Wetzlar

    RECRUITING

    Wetzlar, Hesse, 35578, Germany

  • Johanniter GmbH, Johanniterkrankenhaus

    RECRUITING

    Bonn, North Rhine-Westphalia, 53113, Germany

  • Johanniter Hosptal Bonn

    RECRUITING

    Bonn, North Rhine-Westphalia, 53113, Germany

  • MVZ Onco Medical GmbH Neustadt

    RECRUITING

    Neustadt am Rübenberge, Lower Saxony, 31535, Germany

  • Marien Hospital Bergisch Gladbach,

    RECRUITING

    Bergisch Gladbach, North Rhine-Westphalia, 51465, Germany

  • Marien Hospital Herne, University Hospital der Ruhr-Universität Bochum

    RECRUITING

    Herne, North Rhine-Westphalia, 44625, Germany

  • Medical Office for Urology

    RECRUITING

    Braunschweig, Lower Saxony, 38100, Germany

  • Medical Office for Urology

    RECRUITING

    Herzberg am Harz, Lower Saxony, 37412, Germany

  • Medical Office for Urology

    RECRUITING

    Bayenthal, North Rhine-Westphalia, 50968, Germany

  • Medical Office for Urology

    RECRUITING

    Würselen, North Rhine-Westphalia, 52146, Germany

  • Medical Office for Urology "Urologicum"

    RECRUITING

    Duisburg, North Rhine-Westphalia, 47169, Germany

  • Medical Office for Urology Altstadtquartier Magdeburg

    RECRUITING

    Magdeburg, Lower Saxony, 39104, Germany

  • Medical Office for Urology Nürtingen

    RECRUITING

    Nürtingen, Baden-Wurttemberg, 72622, Germany

  • National Center for Tumor Dieseases (NCT) Heidelberg

    RECRUITING

    Heidelberg, Baden-Wurttemberg, 69120, Germany

  • Praxisgemeinschaft f. Onkologie & Urologie

    RECRUITING

    Wilhelmshaven, Lower Saxony, 26389, Germany

  • St. Bernward Hospital Hildesheim

    RECRUITING

    Hildesheim, Lower Saxony, 31134, Germany

  • St. Bernward Krankenhaus GmbH

    RECRUITING

    Hildesheim, Lower Saxony, 31134, Germany

  • Studienpraxis Urologie

    RECRUITING

    Nürtingen, Baden-Wurttemberg, 72622, Germany

  • Univerity Hospital Schleswig-Holstein

    RECRUITING

    Lübeck, Schleswig-Holstein, 23562, Germany

  • Universital Hospital Gießen & Marburg GmbH, Site: Marburg

    RECRUITING

    Marburg, Hesse, 35043, Germany

  • Universitiy Hospital Gießen und Marburg GmbH, Site: Gießen

    RECRUITING

    Giessen, Hesse, 35392, Germany

  • Universitiy Hospital Halle

    RECRUITING

    Halle, Saxony-Anhalt, 06120, Germany

  • University Hospital Aachen

    RECRUITING

    Aachen, North Rhine-Westphalia, 52074, Germany

  • University Hospital Augsburg

    RECRUITING

    Augsburg, Bavaria, 86156, Germany

  • University Hospital Augsburg

    RECRUITING

    Augsburg, Bavaria, 86156, Germany

  • University Hospital Bonn

    RECRUITING

    Bonn, North Rhine-Westphalia, 53127, Germany

  • University Hospital Düsseldorf

    RECRUITING

    Düsseldorf, North Rhine-Westphalia, 40225, Germany

  • University Hospital Erlangen

    RECRUITING

    Erlangen, Bavaria, 91054, Germany

  • University Hospital Essen

    RECRUITING

    Essen, North Rhine-Westphalia, 45147, Germany

  • University Hospital Frankfurt/Main

    RECRUITING

    Frankfurt am Main, Hesse, 60590, Germany

  • University Hospital Halle

    RECRUITING

    Halle, Saxony-Anhalt, 06120, Germany

  • University Hospital Hamburg-Eppendorf

    RECRUITING

    Hamburg, Free and Hanseatic City of Hamburg, 20246, Germany

  • University Hospital Jena

    RECRUITING

    Jena, Thuringia, 07747, Germany

  • University Hospital Leipzig

    RECRUITING

    Leipzig, Saxony, 04103, Germany

  • University Hospital Magdeburg

    RECRUITING

    Magdeburg, Saxony-Anhalt, 39120, Germany

  • University Hospital Mannheim

    RECRUITING

    Mannheim, Baden-Wurttemberg, 68167, Germany

  • University Hospital Rostock

    RECRUITING

    Rostock, Mecklenburg-Vorpommern, 18057, Germany

  • University Hospital Tübingen

    RECRUITING

    Tübingen, Baden-Wurttemberg, 72076, Germany

  • University Hospital Ulm

    RECRUITING

    Ulm, Baden-Wurttemberg, 89081, Germany

  • University Hospital Wuppertal

    RECRUITING

    Wuppertal, North Rhine-Westphalia, 42283, Germany

  • University Hospital Würzburg

    RECRUITING

    Würzburg, Bavaria, 97080, Germany

  • Universitätsklinikum Freiburg

    RECRUITING

    Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany

  • Urban Hospital Karlsruhe

    RECRUITING

    Karlsruhe, Rhineland-Palatinate, 76133, Germany

  • Urologie Altstadtquartier Magdeburg

    RECRUITING

    Magdeburg, Saxony-Anhalt, 39104, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.